Related references
Note: Only part of the references are listed.Loss of p300 accelerates MDS-associated leukemogenesis
G. Cheng et al.
LEUKEMIA (2017)
Preclinical activity of CPI-0610, a novel small-molecule bromodomain and extra-terminal protein inhibitor in the therapy of multiple myeloma
K. T. Siu et al.
LEUKEMIA (2017)
A Novel LSD1 Inhibitor T-3775440 Disrupts GFI1B-Containing Complex Leading to Transdifferentiation and Impaired Growth of AML Cells
Yoshinori Ishikawa et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Highly effective combination of LSD1 (KDM1A) antagonist and pan-histone deacetylase inhibitor against human AML cells (vol 28, pg 2155, 2014)
W. Fiskus et al.
LEUKEMIA (2017)
Decitabine improves progression-free survival in older high-risk MDS patients with multiple autosomal monosomies: results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group
Michael Luebbert et al.
ANNALS OF HEMATOLOGY (2016)
Targeting p300 Addiction in CBP-Deficient Cancers Causes Synthetic Lethality by Apoptotic Cell Death due to Abrogation of MYC Expression
Hideaki Ogiwara et al.
CANCER DISCOVERY (2016)
N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer
Etienne Dardenne et al.
CANCER CELL (2016)
Targeting Aberrant Epigenetic Networks Mediated by PRMT1 and KDM4C in Acute Myeloid Leukemia
Ngai Cheung et al.
CANCER CELL (2016)
MYC interaction with the tumor suppressive SWI/SNF complex member INI1 regulates transcription and cellular transformation
Angelina Stojanova et al.
CELL CYCLE (2016)
Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia
Zizhen Feng et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
PIM1 kinase inhibition as a targeted therapy against triple-negative breast tumors with elevated MYC expression
Dai Horiuchi et al.
NATURE MEDICINE (2016)
A Myc-driven self-reinforcing regulatory network maintains mouse embryonic stem cell identity
Luca Fagnocchi et al.
NATURE COMMUNICATIONS (2016)
In Vivo Functional Platform Targeting Patient-Derived Xenografts Identifies WDR5-Myc Association as a Critical Determinant of Pancreatic Cancer
Alessandro Carugo et al.
CELL REPORTS (2016)
Decitabine improves outcomes in older patients with acute myeloid leukemia and higher blast counts
Tapan M. Kadia et al.
AMERICAN JOURNAL OF HEMATOLOGY (2015)
Myc and its interactors take shape
William B. Tu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2015)
Preparation of a mixed-matrix hydrogel of vorinostat for topical administration on the rats as experimental model
Wenwen Dai et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors
Dharmendra Dingar et al.
JOURNAL OF PROTEOMICS (2015)
The Role of Histone Demethylase KDM4B in Myc Signaling in Neuroblastoma
Jun Yang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Interaction with WDR5 Promotes Target Gene Recognition and Tumorigenesis by MYC
Lance R. Thomas et al.
MOLECULAR CELL (2015)
Pharmacological targeting of the Wdr5-MLL interaction in C/EBP alpha N-terminal leukemia
Florian Grebien et al.
NATURE CHEMICAL BIOLOGY (2015)
Pre-Anchoring of Pin1 to Unphosphorylated c-Myc in a Fuzzy Complex Regulates c-Myc Activity
Sara Helander et al.
STRUCTURE (2015)
Tricyclic analogues of epidithiodioxopiperazine alkaloids with promising in vitro and in vivo antitumor activity
Marcus Baumann et al.
CHEMICAL SCIENCE (2015)
Lysine-specific demethylase (LSD1/KDM1A) and MYCN cooperatively repress tumor suppressor genes in neuroblastoma
Stefano Amente et al.
ONCOTARGET (2015)
BRD4-targeted therapy induces Myc-independent cytotoxicity in Gnaq/11-mutatant uveal melanoma cells
Grazia Ambrosini et al.
ONCOTARGET (2015)
The Role of Histone Demethylase KDM4B in Myc Signaling in Neuroblastoma
Jun Yang et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo
J. M. Gajer et al.
ONCOGENESIS (2015)
MYC: connecting selective transcriptional control to global RNA production
Theresia R. Kress et al.
NATURE REVIEWS CANCER (2015)
The interplay between histone deacetylases and c-Myc in the transcriptional suppression of HPP1 in colon cancer
Jian Wang et al.
CANCER BIOLOGY & THERAPY (2014)
MYC through miR-17-92 Suppresses Specific Target Genes to Maintain Survival, Autonomous Proliferation, and a Neoplastic State
Yulin Li et al.
CANCER CELL (2014)
BET Protein Inhibitor JQ1 Attenuates Myc-Amplified MCC Tumor Growth In Vivo
Qiang Shao et al.
CANCER RESEARCH (2014)
BET Bromodomain Inhibition of MYC-Amplified Medulloblastoma
Pratiti Bandopadhayay et al.
CLINICAL CANCER RESEARCH (2014)
Distinct and Combinatorial Functions of Jmjd2b/Kdm4b and Jmjd2c/Kdm4c in Mouse Embryonic Stem Cell Identity
Partha Pratim Das et al.
MOLECULAR CELL (2014)
Targeting MLL1 H3K4 Methyltransferase Activity in Mixed-Lineage Leukemia
Fang Cao et al.
MOLECULAR CELL (2014)
Selective transcriptional regulation by Myc in cellular growth control and lymphomagenesis
Arianna Sabo et al.
NATURE (2014)
Activation and repression by oncogenic MYC shape tumour-specific gene expression profiles
Susanne Walz et al.
NATURE (2014)
The interaction of MYC with the trithorax protein ASH2L promotes gene transcription by regulating H3K27 modification
Andrea Ullius et al.
NUCLEIC ACIDS RESEARCH (2014)
Dynamic Rearrangement of F-Actin Is Required to Maintain the Antitumor Effect of Trichostatin A
Dong-Hee Yang et al.
PLOS ONE (2014)
BET and HDAC inhibitors induce similar genes and biological effects and synergize to kill in Myc-induced murine lymphoma
Joydeep Bhadury et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Rational design and validation of a Tip60 histone acetyltransferase inhibitor
Chunxia Gao et al.
SCIENTIFIC REPORTS (2014)
MYC and Transcription Elongation
Peter B. Rahl et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2014)
Polycomb repressive complex 2 (PRC2) suppresses Eμ-myc lymphoma
Stanley C. W. Lee et al.
BLOOD (2013)
Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
Jakob Loven et al.
CELL (2013)
Histone methyltransferase Suv39h1 deficiency prevents Myc-induced chromosomal instability in murine myeloid leukemias
Beate Vajen et al.
GENES CHROMOSOMES & CANCER (2013)
Physical Interaction between MYCN Oncogene and Polycomb Repressive Complex 2 (PRC2) in Neuroblastoma FUNCTIONAL AND THERAPEUTIC IMPLICATIONS
Daisy Corvetta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Decitabine represses translocated MYC oncogene in Burkitt lymphoma
Hanfeng Guan et al.
JOURNAL OF PATHOLOGY (2013)
Quantitative Dissection and Stoichiometry Determination of the Human SET1/MLL Histone Methyltransferase Complexes
Rick van Nuland et al.
MOLECULAR AND CELLULAR BIOLOGY (2013)
Proteomic and bioinformatic analysis of mammalian SWI/SNF complexes identifies extensive roles in human malignancy
Cigall Kadoch et al.
NATURE GENETICS (2013)
被撤回的出版物: Coordinated Silencing of MYC-Mediated miR-29 by HDAC3 and EZH2 as a Therapeutic Target of Histone Modification in Aggressive B-Cell Lymphomas (Retracted article. See vol. 41, pg. 1198, 2023)
Xinwei Zhang et al.
CANCER CELL (2012)
Transcriptional Amplification in Tumor Cells with Elevated c-Myc
Charles Y. Lin et al.
CELL (2012)
High frequency of BTG1 deletions in acute lymphoblastic leukemia in children with down syndrome
Catarina Lundin et al.
GENES CHROMOSOMES & CANCER (2012)
Loss of Dnmt3b function upregulates the tumor modifier Ment and accelerates mouse lymphomagenesis
Ryan A. Hlady et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Myc Regulates the Transcription of the PRC2 Gene To Control the Expression of Developmental Genes in Embryonic Stem Cells
Francesco Neri et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
Michael T. McCabe et al.
NATURE (2012)
The genetic basis of early T-cell precursor acute lymphoblastic leukaemia
Jinghui Zhang et al.
NATURE (2012)
Characterisation of a Tip60 Specific Inhibitor, NU9056, in Prostate Cancer
Kelly Coffey et al.
PLOS ONE (2012)
The Origin and Nature of Tightly Clustered BTG1 Deletions in Precursor B-Cell Acute Lymphoblastic Leukemia Support a Model of Multiclonal Evolution
Esme Waanders et al.
PLOS GENETICS (2012)
Intrathecal 5-azacytidine inhibits global DNA methylation and methyl- CpG-binding protein 2 expression and alleviates neuropathic pain in rats following chronic constriction injury
Ying Wang et al.
BRAIN RESEARCH (2011)
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Jake E. Delmore et al.
CELL (2011)
The regulatory role of c-MYC on HDAC2 and PcG expression in human multipotent stem cells
Dilli Ram Bhandari et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2011)
SWI/SNF nucleosome remodellers and cancer
Boris G. Wilson et al.
NATURE REVIEWS CANCER (2011)
Pim1 promotes human prostate cancer cell tumorigenicity and c-MYC transcriptional activity
Jongchan Kim et al.
BMC CANCER (2010)
Tumor Stroma-Derived TGF-β Limits Myc-Driven Lymphomagenesis via Suv39h1-Dependent Senescence
Maurice Reimann et al.
CANCER CELL (2010)
c-Myc Regulates Transcriptional Pause Release
Peter B. Rahl et al.
CELL (2010)
TGFbeta-dependent gene expression shows that senescence correlates with abortive differentiation along several lineages in Myc-induced lymphomas
Judith Mueller et al.
CELL CYCLE (2010)
The interaction between Myc and Miz1 is required to antagonize TGFβ-dependent autocrine signaling during lymphoma formation and maintenance
Jan van Riggelen et al.
GENES & DEVELOPMENT (2010)
Lysine Methylation Regulates E2F1-Induced Cell Death
Haroula Kontaki et al.
MOLECULAR CELL (2010)
Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
Thomas Ernst et al.
NATURE GENETICS (2010)
Transcriptional upregulation of histone deacetylase 2 promotes Myc-induced oncogenic effects
G. M. Marshall et al.
ONCOGENE (2010)
LSD1-mediated demethylation of histone H3 lysine 4 triggers Myc-induced transcription
S. Amente et al.
ONCOGENE (2010)
Pim1 kinase synergizes with c-MYC to induce advanced prostate carcinoma
J. Wang et al.
ONCOGENE (2010)
Aberrant DNA methylation is a dominant mechanism in MDS progression to AML
Ying Jiang et al.
BLOOD (2009)
Sin3B Expression Is Required for Cellular Senescence and Is Up-regulated upon Oncogenic Stress
Kathryn B. Grandinetti et al.
CANCER RESEARCH (2009)
DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation
Tina Branscombe Miranda et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Epigenetic Silencing of the RASSF1A Tumor Suppressor Gene through HOXB3-Mediated Induction of DNMT3B Expression
Rajendra Kumar Palakurthy et al.
MOLECULAR CELL (2009)
Mechanisms of Polycomb gene silencing: knowns and unknowns
Jeffrey A. Simon et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors
Nagma Khan et al.
BIOCHEMICAL JOURNAL (2008)
N-Myc Regulates a Widespread Euchromatic Program in the Human Genome Partially Independent of Its Role as a Classical Transcription Factor
Rebecca Cotterman et al.
CANCER RESEARCH (2008)
Myc-mediated transcriptional repression by recruitment of histone deacetylase
John F. Kurland et al.
CANCER RESEARCH (2008)
Induction of a novel histone deacetylase 1/c-Myc/Mnt/Max complex formation is implicated in parity-induced refractoriness to mammary carcinogenesis
Yoichiro Matsuoka et al.
CANCER SCIENCE (2008)
A chromatin-wide transition to H4K20 monomethylation impairs genome integrity and programmed DNA rearrangements in the mouse
Gunnar Schotta et al.
GENES & DEVELOPMENT (2008)
MYC translocation and an increased copy number predict poor prognosis in adult diffuse large B-cell lymphoma (DLBCL), especially in germinal centre-like B cell (GCB) type
S. O. Yoon et al.
HISTOPATHOLOGY (2008)
Ezh2 requires PHF1 to efficiently catalyze h3 lysine 27 trimethylation in vivo
Kavitha Sarma et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Ezh1 and Ezh2 Maintain Repressive Chromatin through Different Mechanisms
Raphael Margueron et al.
MOLECULAR CELL (2008)
Pim kinase-dependent inhibition of c-Myc degradation
Y. Zhang et al.
ONCOGENE (2008)
Analysis of Myc-Induced Histone Modifications on Target Chromatin
Francesca Martinato et al.
PLOS ONE (2008)
Specific requirement of the chromatin modifier mSin3B in cell cycle exit and cellular differentiation
Gregory David et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Combined Analysis of Murine and Human Microarrays and ChIP Analysis Reveals Genes Associated with the Ability of MYC To Maintain Tumorigenesis
Chi-Hwa Wu et al.
PLOS GENETICS (2008)
Brd4 recruits P-TER to chromosomes at late mitosis to promote G1 gene expression and cell cycle progression
Zhiyuan Yang et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Certain and progressive methylation of histone H4 at lysine 20 during the cell cycle
James J. Pesavento et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
STAGA recruits mediator to the MYC oncoprotein to stimulate transcription and cell proliferation
Xiaohui Liu et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Cyclin D1 is transcriptionally down-regulated by ZO-2 via an E box and the transcription factor c-Myc
Miriam Huerta et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Activation of tissue transglutaminase transcription by histone deacetylase inhibition as a therapeutic approach for Myc oncogenesis
Tao Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Phosphorylation of histone H3 at Ser10 facilitates RNA polymerase II release from promoter-proximal pausing in Drosophila
M. Soledad Ivaldi et al.
GENES & DEVELOPMENT (2007)
Reduced body size and decreased intestinal tumor rates in HDAC2-mutant mice
Stephan Zimmermann et al.
CANCER RESEARCH (2007)
Protein arginine-methyltransferase-dependent oncogenesis
Ngai Cheung et al.
NATURE CELL BIOLOGY (2007)
TRRAP and GCN5 are used by c-Myc to activate RNA polymerase III transcription
Niall S. Kenneth et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
p53 is regulated by the lysine demethylase LSD1
Jing Huang et al.
NATURE (2007)
Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation
Chi-Hwa Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation
Alessio Zippo et al.
NATURE CELL BIOLOGY (2007)
Chromatin profiling of Epstein-Barr virus latency control region
Latasha Day et al.
JOURNAL OF VIROLOGY (2007)
Pharmacologic disruption of polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells
Jing Tan et al.
GENES & DEVELOPMENT (2007)
The Trithorax group protein Lid is a trimethyl histone H3K4 demethylase required for dMyc-induced cell growth
Julie Secombe et al.
GENES & DEVELOPMENT (2007)
Inhibition of a protein-protein interaction between INI1 and c-Myc by small peptidomimetic molecules inspired by Helix-1 of c-Myc: identification of a new target of potential antineoplastic interest
L. Bagnasco et al.
FASEB JOURNAL (2007)
The Drosophila histone acetyltransferase Gcn5 and transcriptional adaptor Ada2a are involved in nucleosomal histone H4 acetylation
Anita Ciurciu et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Global mapping of c-Myc binding sites and target gene networks in human B cells
Karen I. Zeller et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Expression of ΔDNMT3B variants and its association with promoter methylation of p16 and RASSF1A in primary non-small cell lung cancer
Jie Wang et al.
CANCER RESEARCH (2006)
Valproate inhibition of histone deacetylase 2 affects differentiation and decreases proliferation of endometrial stromal sarcoma cells
Andelko Hrzenjak et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Regulation of MLL1 H3K4 methyltransferase activity by its core components
Yali Dou et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2006)
Myc-binding-site recognition in the human genome is determined by chromatin context
Ernesto Guccione et al.
NATURE CELL BIOLOGY (2006)
Myc influences global chromatin structure
Paul S. Knoepfler et al.
EMBO JOURNAL (2006)
Reversal of histone lysine trimethylation by the JMJD2 family of histone demethylases
Johnathan R. Whetstine et al.
CELL (2006)
Decitabine improves patient outcomes in myelodysplastic syndromes - Resuits of a Phase III randomized study
H Kantarjian et al.
CANCER (2006)
The Polycomb group protein EZH2 directly controls DNA methylation
E Viré et al.
NATURE (2006)
Regulation of Epstein-Barr virus latency type by the chromatin boundary factor CTCF
Charles M. Chau et al.
JOURNAL OF VIROLOGY (2006)
Dual regulation of c-Myc by p300 via acetylation-dependent control of Myc protein turnover and coactivation of Myc-induced transcription
F Faiola et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
The ubiquitin ligase HectH9 regulates transcriptional activation by myc and is essential for tumor cell proliferation
S Adhikary et al.
CELL (2005)
Six lysine residues on c-Myc are direct substrates for acetylation by p300
KL Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Metastasis-associated protein 1 (MTA1) is an essential downstream effector of the c-MYC oncoprotein
XY Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Regulation of LSD1 histone demethylase activity by its associated factors
YJ Shi et al.
MOLECULAR CELL (2005)
LSD1 demethylates repressive histone marks to promote androgen-receptor-dependent transcription
E Metzger et al.
NATURE (2005)
Myc interacts genetically with Tip48/Reptin and Tip49/Pontin to control growth and proliferation during Drosophila development
P Bellosta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Oncogene-induced senescence as an initial barrier in lymphoma development
M Braig et al.
NATURE (2005)
Transcriptional regulation and transformation by MYC proteins
S Adhikary et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer
MF Fraga et al.
NATURE GENETICS (2005)
Pontin and Reptin regulate cell proliferation in early Xenopus embryos in collaboration with c-Myc and Miz-1
C Etard et al.
MECHANISMS OF DEVELOPMENT (2005)
A conserved element in Myc that negatively regulates its proapoptotic activity
A Herbst et al.
EMBO REPORTS (2005)
Myc represses transcription through recruitment of DNA methyltransferase corepressor
C Brenner et al.
EMBO JOURNAL (2005)
A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells
E Yeh et al.
NATURE CELL BIOLOGY (2004)
Valproic acid inhibits angiogenesis in vitro and in vivo
M Michaelis et al.
MOLECULAR PHARMACOLOGY (2004)
HBP1 and Mad1 repressors bind the Sin3 corepressor PAH2 domain with opposite helical orientations
KA Swanson et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2004)
Histone demethylation mediated by the nuclear arnine oxidase homolog LSD1
YJ Shi et al.
CELL (2004)
The c-MYC oncoprotein is a substrate of the acetyltransferases hGCN5/PCAF and TIP60
JH Patel et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin
G Schotta et al.
GENES & DEVELOPMENT (2004)
Multiple cell-type-specific elements regulate Myc protein stability
A Herbst et al.
ONCOGENE (2004)
Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis
P Zhu et al.
CANCER CELL (2004)
UCSF chimera - A visualization system for exploratory research and analysis
EF Pettersen et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
c-Myc recruits P-TEFb for transcription, cellular proliferation and apoptosis
S Kanazawa et al.
ONCOGENE (2003)
The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2
OH Krämer et al.
EMBO JOURNAL (2003)
MYC recruits the TIP60 histone acetyltransferase complex to chromatin
SR Frank et al.
EMBO REPORTS (2003)
C-Myc transformation domain recruits the human STAGA complex and requires TRRAP and GCN5 acetylase activity for transcription activation
XH Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP
J Vervoorts et al.
EMBO REPORTS (2003)
Genomic targets of the human c-Myc protein
PC Fernandez et al.
GENES & DEVELOPMENT (2003)
Mad4 is regulated by a transcriptional repressor complex that contains Miz-1 and c-Myc
L Kime et al.
BIOCHEMICAL JOURNAL (2003)
X-ray structures of Myc-Max and Mad-Max recognizing DNA: Molecular bases of regulation by proto-oncogenic transcription factors
SK Nair et al.
CELL (2003)
Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter
SQ Wu et al.
ONCOGENE (2003)
An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets
KI Zeller et al.
GENOME BIOLOGY (2003)
Myc recruits P-TEFb to mediate the final step in the transcriptional activation of the cad promoter
SR Eberhardy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells
M van de Wetering et al.
CELL (2002)
The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin
LM Butler et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Interaction of PRMT1 with BTG/TOB proteins in cell signalling: molecular analysis and functional aspects
C Berthet et al.
GENES TO CELLS (2002)
c-Myc mediates activation of the cad promoter via a post-RNA polymerase II recruitment mechanism
SR Eberhardy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
M Göttlicher et al.
EMBO JOURNAL (2001)
Loss of the Suv39h histone methyltransferases impairs mammalian heterochromatin and genome stability
AHFM Peters et al.
CELL (2001)
The p400 complex is an essential E1A transformation target
M Fuchs et al.
CELL (2001)
Proliferation, cell cycle and apoptosis in cancer
GI Evan et al.
NATURE (2001)
Myc represses the p21(WAF1/CIP1) promoter and interacts with Sp1/Sp3
AL Gartel et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Repression of p15INK4b expression by Myc through association with Miz-1
P Staller et al.
NATURE CELL BIOLOGY (2001)
TGFβ influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b
J Seoane et al.
NATURE CELL BIOLOGY (2001)
Stable histone deacetylase complexes distinguished by the presence of SANT domain proteins CoREST/kiaa0071 and Mta-L1
GW Humphrey et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability
R Sears et al.
GENES & DEVELOPMENT (2000)
An ATPase/helicase complex is an essential cofactor for oncogenic transformation by c-Myc
MA Wood et al.
MOLECULAR CELL (2000)
The essential cofactor TRRAP recruits the histone acetyltransferase hGCN5 to c-Myc
SB McMahon et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Low-dose 5-aza-2 '-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: A multicenter phase II study in elderly patients
P Wijermans et al.
JOURNAL OF CLINICAL ONCOLOGY (2000)
Share Paper
